Fundraising Fox

uMed

4 known investors

uMed provides data and insights infrastructure to accelerate the development and delivery of new medicines by addressing evidence gaps across the therapy lifecycle. The company enables access to clinical research data and patient insights for pharmaceutical companies, researchers, and healthcare institutions developing new treatments.

AI & Machine LearningBiotechData & InfrastructureDigital HealthHealthtechMedical Devices

Investors · 4

11.2 CapitalLas Vegas · $500K – $3M
AlbionVCLondon
Delin VenturesreportedLondon · $216K – $2.2M
Playfair CapitalreportedLondon · $130K – $1.9M

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

uMed raises £9.8m to boost participation in clinical trials, expanding to N.America - uMed (UK)umed.io · Jul 2023Clinical research platform uMed raises £10m to tackle slump in UK trials | Money News | Sky Newsnews.sky.com · Jul 2023British health tech startup uMed raises cash for next-gen clinical trial work | Fierce Biotechfiercebiotech.com · Dec 2020uMed raises a £3.7m seed round - Albion Capitalalbion.capital · Dec 2020uMed raises funds to grow automated platform for research | Healthcare Digitalhealthcare-digital.com · Nov 2020uMed raises $4.8m in venture capital funding to help healthcare providers participate in more clinical studies | by Matt Wilson | uMed | Mediummedium.com · Nov 2020

Frequently asked questions

What does uMed do?
uMed provides data and insights infrastructure to accelerate the development and delivery of new medicines by addressing evidence gaps across the therapy lifecycle. The company enables access to clinical research data and patient insights for pharmaceutical companies, researchers, and healthcare institutions developing new treatments.
Who are uMed's investors?
uMed's investors include 11.2 Capital, AlbionVC, Delin Ventures, Playfair Capital.